Co-administration of dexamethasone increases severity and accelerates onset day of neutropenia in bladder cancer patients on methotrexate, vinblastine, adriamycin and cisplatin chemotherapy: a retrospective cohort study

BACKGROUND: Bladder cancer patients receiving methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy are co-administered with dexamethasone as an anti-emetic. We examined whether or not dexamethasone affects the severity and onset day of MVAC-induced severe neutropenia. METHODS: Thi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Pharm Health Care Sci
Main Authors: Itai, Shingo, Suga, Yukio, Hara, Yusuke, Izumi, Kouji, Maeda, Yuji, Kitagawa, Yasuhide, Ishizaki, Junko, Shimada, Tsutomu, Mizokami, Atsushi, Sai, Yoshimichi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5225533/
https://ncbi.nlm.nih.gov/pubmed/28097015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-016-0072-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados